PUBLICATIONS · 35437610
Purine nucleoside analogs plus rituximab are an effective treatment choice for hairy cell leukemia-variant.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Ann Hematol
- Publication date
- 2022 Jun
- First author
- Wang Y
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Wang Y
- type
- Author
- name
- Wang T
- type
- Author
- name
- Yu Y
- type
- Author
- name
- Wang Q
- type
- Author
- name
- Yan Y
- type
- Author
- name
- Li R
- type
- Author
- name
- Sun Q
- type
- Author
- name
- Xiong W
- type
- Author
- name
- Lyu R
- type
- Author
- name
- Yu Z
- type
- Author
- name
- Liu W
- type
- Author
- name
- Sui W
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Wang Y
- type
- Author
- name
- Wang T
- type
- Author
- name
- Yu Y
- type
- Author
- name
- Wang Q
- type
- Author
- name
- Yan Y
- type
- Author
- name
- Li R
- type
- Author
- name
- Sun Q
- type
- Author
- name
- Xiong W
- type
- Author
- name
- Lyu R
- type
- Author
- name
- Yu Z
- type
- Author
- name
- Liu W
- type
- Author
- name
- Sui W
- type
- Author
- bibliography ids
- nci-bib-1505f0cdc34c26a66400c5fe
- book metadata
- content sha256
- 5903dd840e8394e1c4a39867a30da522d8273ff9fa9f643ad4761a29815f0806
- document type
- citation
- dois
- 10.1007/s00277-022-04795-x
- electronic publication date
- display
- 2022 Apr 18
- precision
- day
- year
- 2022
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:35437610
- immutable id
- pubmed:35437610@5903dd840e8394e1c4a39867a30da522d8273ff9fa9f643ad4761a29815f0806
- journal
- abbreviation
- Ann Hematol
- issn electronic
- 1432-0584
- issn print
- 0939-5555
- issue
- 6
- name
- Annals of hematology
- nlm unique id
- 9107334
- pages
- 1201-1210
- volume
- 101
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 35437610
- provenance
- batch id
- 9d150d55960e0c12aada
- provider
- NCBI PubMed ESummary
- record sha256
- 80f535b22b767b1b4e8aa7962f07ef62f1a977a68abe3e9e49b50302a90a9a73
- response sha256
- 2d4ef1cc8137eef6e7216f66bf8601c3899bc663b8626f412794d39585de6b6b
- retrieved at
- 2026-09-09T23:48:09.820498+00:00
- publication date
- display
- 2022 Jun
- precision
- month
- year
- 2022
- publication types
- Journal Article
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Purine nucleoside analogs plus rituximab are an effective treatment choice for hairy cell leukemia-variant.
Preserved source evidence · Not medical advice
Triangle